Log in to save to my catalogue

Gangliosides profiling in serum of breast cancer patient: GM3 as a potential diagnostic biomarker

Gangliosides profiling in serum of breast cancer patient: GM3 as a potential diagnostic biomarker

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2257700880

Gangliosides profiling in serum of breast cancer patient: GM3 as a potential diagnostic biomarker

About this item

Full title

Gangliosides profiling in serum of breast cancer patient: GM3 as a potential diagnostic biomarker

Publisher

New York: Springer US

Journal title

Glycoconjugate journal, 2019-10, Vol.36 (5), p.419-428

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Gangliosides altered during the pathological conditions and particularly in cancers. Here, we aimed to profile the gangliosides in breast cancer serum and propose potential biomarkers. LC-FTMS method was first used to identify all the ganglioside species in serum, then LC-MS/MS-MRM method was employed to quantitate the levels of gangliosides in ser...

Alternative Titles

Full title

Gangliosides profiling in serum of breast cancer patient: GM3 as a potential diagnostic biomarker

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2257700880

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2257700880

Other Identifiers

ISSN

0282-0080

E-ISSN

1573-4986

DOI

10.1007/s10719-019-09885-z

How to access this item